Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
FRANKFURT AM MAIN, Germany, March 17, 2026 (GLOBE NEWSWIRE) -- Anbio Biotechnology (NASDAQ: NNNN) (
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System
Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak...
Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News
The past week has seen a flurry of activity across various sectors, with several small- and mid-cap stocks delivering notable gains and drawing significant investor attention. From healthcare innovators...
Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions
Accelerating Expansion Across Human and Veterinary Health Through Innovation and Strategic Collaboration...